This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Guédez, Y. Articles by Kotb, M. Search for Related Content PubMed PubMed Citation Articles by Guédez, Y. Articles by Kotb, M. Related Collections Gene expression Valvular heart disease

(Circulation. 1999;99:2784-2790.)
© 1999 American Heart Association, Inc.

Clinical Investigation and Reports

HLA Class II Associations With Rheumatic Heart Disease Are More Evident and Consistent Among Clinically Homogeneous Patients

Yajaira Guédez, MD; Alyaa Kotby, MD; Maha El-Demellawy, PhD; Ashraf Galal, MD; Glenys Thomson, PhD; Salah Zaher, MD; Samir Kassem, MD; Malak Kotb, PhD

From the Veterans Affairs Medical Center (Y.G., M.E., M.K.) and The University of Tennessee, Departments of Surgery, Microbiology, and Immunology (Y.G., M.E., M.K.), Memphis; the Pediatrics Department, Faculty of Medicine, Ain Shams University, Cairo (A.K.) and Alexandria University (A.G., S.Z., S.K.), Egypt; and the Department of Integrative Biology, University of California, Berkeley (G.T.).

Correspondence to Malak Kotb, PhD, University of Tennessee, Memphis, 956 Court Ave, Suite A202, Memphis, TN 38163. E-mail mkotb{at}utmem1.utmem.edu

Background—Discrepancies in reported HLA class II associations with rheumatic heart disease (RHD) may have been due to inaccuracies of serological typing reagents and/or lack of defined clinical classification of patients analyzed. The molecular association between HLA and RHD was investigated in patients with defined clinical outcome.

Methods and Results—Class II allele/haplotype distribution was determined in 2 groups of RHD patients (n=88) and a control group (n=59). Patients were divided into the mitral valve disease (MVD) category (ie, those with mitral regurgitation with or without mitral stenosis) and the multivalvular lesions (MVL) category, with impairment of aortic and/or tricuspid valves in addition to mitral valve damage. The MVD category (n=65) accounted for 74% of patients and included significantly fewer recurrent RF episodes compared with MVL patients (P=0.002).

Conclusions—Significant increases in DRB1*0701 and DQA1*0201 alleles and DRB1*0701-DQA1*0201 haplotypes were found in patients. Removal of the MVL patients from analysis increased the strength of HLA associations among the MVD sample. The frequency of DQA1*0103 allele was decreased and the DQB1*0603 allele was absent from the patient group, suggesting that these alleles may confer protective effects against RHD. DQ alleles in linkage disequilibrium with DR alleles appear to influence risk/protection effect: whereas the DRB1*13–DQA1*0501-3–DQB1*0301 haplotype showed a trend toward risk, the DRB1*13-DQA1*0103-DQB1*0603 haplotype was absent in the RHD sample. Our data indicate that certain class II alleles/haplotypes are associated with risk or protection from RHD and that these associations appear to be stronger and more consistent when analyzed in patients with relatively more homogeneous clinical manifestations.

Key Words: rheumatic heart disease • antigens • genetics

This article has been cited by other articles:

				P. A. Bryant, R. Robins-Browne, J. R. Carapetis, and N. Curtis Some of the People, Some of the Time: Susceptibility to Acute Rheumatic Fever Circulation, February 10, 2009; 119(5): 742 - 753. [Abstract] [Full Text] [PDF]

				M. M. Nooh, N. El-Gengehi, R. Kansal, C. S. David, and M. Kotb HLA Transgenic Mice Provide Evidence for a Direct and Dominant Role of HLA Class II Variation in Modulating the Severity of Streptococcal Sepsis J. Immunol., March 1, 2007; 178(5): 3076 - 3083. [Abstract] [Full Text] [PDF]

				N. M. J. Ellis, Y. Li, W. Hildebrand, V. A. Fischetti, and M. W. Cunningham T Cell Mimicry and Epitope Specificity of Cross-Reactive T Cell Clones from Rheumatic Heart Disease J. Immunol., October 15, 2005; 175(8): 5448 - 5456. [Abstract] [Full Text] [PDF]

				L. Guilherme, S. E. Oshiro, K. C. Fae, E. Cunha-Neto, G. Renesto, A. C. Goldberg, A. C. Tanaka, P. M. A Pomerantzeff, M. H. Kiss, C. Silva, et al. T-Cell Reactivity against Streptococcal Antigens in the Periphery Mirrors Reactivity of Heart-Infiltrating T Lymphocytes in Rheumatic Heart Disease Patients Infect. Immun., September 1, 2001; 69(9): 5345 - 5351. [Abstract] [Full Text] [PDF]

				M. W. Cunningham Pathogenesis of Group A Streptococcal Infections Clin. Microbiol. Rev., July 1, 2000; 13(3): 470 - 511. [Abstract] [Full Text] [PDF]

				L. Guilherme, N. Dulphy, C. Douay, V. Coelho, E. Cunha-Neto, S. E. Oshiro, R. V Assis, A. C. Tanaka, P. M. Alberto Pomerantzeff, D. Charron, et al. Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients Int. Immunol., July 1, 2000; 12(7): 1063 - 1074. [Abstract] [Full Text] [PDF]